- Home
- MLTX vs CBL Comparison
MLTX vs CBL Comparison
Compare MLTX & CBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLTX | CBL |
|---|---|---|
| Founded | 2021 | 1978 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MLTX | CBL |
|---|---|---|
| Price | $18.46 | $58.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | $27.50 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 1.1M | 279.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.00% |
| EPS Growth | N/A | ★ 132.09 |
| EPS | N/A | ★ 1.48 |
| Revenue | N/A | ★ $578,373,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $39.52 |
| Revenue Growth | N/A | ★ 12.18 |
| 52 Week Low | $5.95 | $26.54 |
| 52 Week High | $62.75 | $60.40 |
Technical Indicators
Market Signals| Indicator | MLTX | CBL |
|---|---|---|
| Relative Strength Index (RSI) | 45.13 | 65.12 |
| Support Level | $15.54 | $46.65 |
| Resistance Level | $19.24 | N/A |
| Average True Range (ATR) | 0.98 | 1.70 |
| MACD | -0.15 | 0.19 |
| Stochastic Oscillator | 5.17 | 74.61 |
Price Performance
Historical ComparisonAbout MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
About CBL CBL & Associates Properties Inc.
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.